🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 78

  1. US 12419873

    Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12419941

    Poultry drinking water-based vaccine delivery system and method

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12415845

    Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12410259

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12410240

    Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12404317

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12397066

    Delivery of gene therapy treatments

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12398123

    Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12391742

    Anti-KRAS-G12D T cell receptors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12383618

    Expression vector delivery system and use thereof for inducing an immune response

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12383554

    Compositions and methods to protect mammalian tissue against cold and other metabolic stresses

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12384820

    Griffithsin mutants

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12383500

    Nanoliposome compositions and methods of using the same

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12385010

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12377135

    GHRH antagonists for use in a method of treating sarcoidosis

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12378248

    A1 adenosine receptor agonists and methods of use thereof

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12371500

    Il-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12370255

    Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12364745

    Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12365722

    Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 12365653

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 12357599

    Prodrugs of treprostinil

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 12357615

    Compositions for the treatment of brain tumors

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 12351625

    Therapeutic antibodies against osteopontin

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 12350322

    Peptide immunogens targeting interleukin 6 (IL-6) and formulations thereof for immunotherapy of diseases impacted by IL-6 dysregulation

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 12350274

    Nucleotide analogs

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 12344842

    Compositions and methods for treating and preventing macular degeneration

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 12343432

    Encapsulated probiotic

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 12336974

    Methods and compositions for preventing and treating auditory dysfunctions

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 12331105

    Broadly neutralizing antibodies against HIV

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 12325688

    Gingerenone A prodrugs as sensotherapeutics and methods of use

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 12312391

    Anti-mutated KRAS T cell receptors

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 12311016

    Biomarkers and immunogenic compositions for filarial parasites

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 12310992

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 12304940

    HLA class II-restricted t cell receptors against mutated RAS

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 12298315

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 12296004

    Recombinant virus with diminished latency and methods of using same

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 12296013

    Photosensitizing antibody-fluorophore conjugates

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 12292441

    Recombinant Acinetobacter baumannii strain AB5075

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 12286657

    Methods and compositions

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 12286405

    Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 12285478

    Foot-and-mouth disease vaccine

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 12281060

    Remodilins for airway remodeling and organ fibrosis

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 12281336

    Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 12275758

    Prefusion RSV F proteins and their use

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 12274741

    Cattle fever tick-infestation vaccines and uses thereof

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 12274684

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 12274723

    Bacteriophage compositions and methods for treatment of bacterial infections

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.